News by Country: Afghanistan

Close to 120 companies across the globe claim to possess the required expertise (Roots Analysis)
Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment

April 14, 2021

The HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030
Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030”,

April 14, 2021

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing (Roots Analysis)
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers

April 14, 2021

“Oligonucleotide Synthesis, Modification and Purification Services Market”
A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications.

April 14, 2021

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations.
Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios

April 14, 2021

Modification and purification services market is projected to grow at an annualized rate of ~10%,
Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.””

April 14, 2021

The oligonucleotide synthesis market is estimated to be worth USD 5.8 billion in 2030,
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis

April 14, 2021

‘Biologics Fill / Finish Service Providers, 2019-2030’ (By Roots Analysis)
A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage)

April 13, 2021

Over 115 companies located in various regions across the globe claim to provide contract fill / finish (Roots Analysis)
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols

April 13, 2021

Biologics market is projected to grow at an annualized rate of ~10%, (till 2030)
Vials represent the most prominent form of packaging used for biopharmaceutical interventions; with increasing demand for self-administration devices, syringes have also garnered significant attention

April 13, 2021

The contract fill / finish services market for biologics , (predicts Roots Analysis)
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers

April 13, 2021

‘Global Preventive Vaccines Market, 2020-2030’ (By Roots Analysis)
A detailed assessment of the current market landscape, including information on type of developer (industry, non-industry, industry / non-industry)

April 13, 2021

More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development.
Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines

April 13, 2021

The global preventive vaccines market is growing at a CAGR of 10.7% (claims Roots Analysis)
Roots Analysis has done a detailed report on Global Preventive Vaccines Market, 2020-2030”, covering key aspects of the industry and identifying potential future growth opportunities.

April 13, 2021

Global preventive vaccines market is projected to be worth USD 94 billion by 2030 (Roots Analysis)
Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list

April 13, 2021

“Microbial Contract Biomanufacturing Market, 2020-2030’’
A detailed review of the current landscape of companies offering contract manufacturing services for biologics

April 12, 2021

Over 115 companies, across the world, claim to offer a variety of product development
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems

April 12, 2021

The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%,
Roots Analysis has done a detailed study on Microbial Contract Biomanufacturing Market, 2020-2030, covering key aspects of the industry and identifying potential future growth opportunities.

April 12, 2021

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines

April 12, 2021

Microbial contract biomanufacturing market is growing at a CAGR of 8.7%,
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies

April 12, 2021

“STING Pathway Targeting Therapeutics and Technologies, 2020-2030”
A detailed assessment of the current market landscape of therapeutics targeting STING pathway, based on several parameters, such as type of STING modulator

April 12, 2021

Many small / macro molecule-based STING pathway modulators are currently being evaluated
In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community

April 12, 2021

The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%,
Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”

April 12, 2021

STING pathway targeting technologies market, is anticipated to be worth over USD 2.8 billion by 2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”

April 12, 2021

Diablo II: Resurrected will let you import your 20-year-old savegames
We have a huge selection of Diablo Gold and Items on voidk.com. We are the best store to buy diablo 2 items. We have cheap prices and fast delivery.

April 10, 2021

“Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030”
A detailed assessment of the current market landscape, including information on drug developer(s), phase of development

April 9, 2021

The potential of nearly 300 next generation immune checkpoint modulators for the treatment (Roots Analysis)
Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory

April 9, 2021

Inhibitors and stimulators market is projected to grow at an annualized rate of ~15% (till 2030)
Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.

April 9, 2021

The next generation immune checkpoint inhibitors and stimulators market (Roots Analysis)
Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential

April 9, 2021

“Endocannabinoid System Targeted Therapeutics Market, 2020-2030”
A detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development

April 9, 2021

Presently engaged in evaluating the clinical applications of over 180 cannabinoid-derivatives
Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically

April 9, 2021

The endocannabinoid system is projected to grow at an annualized rate of ~30%, (till 2030)
Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “

April 9, 2021

The endocannabinoid system targeted therapeutics market < Roots Analysis>
So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting

April 9, 2021

Endocannabinoid system targeted therapeutics market is growing at an annualized rate of 30%, (Roots Analysis)
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence

April 9, 2021

“Proteome Profiling Services Market, 2020-2030” (Roots Analysis)
A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider

April 8, 2021

The market is fragmented featuring the presence of both industry and non industry players Roots Analysis
With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive

April 8, 2021

Proteome profiling services market is projected to grow at an annualized rate of ~15% (till 2030)
Roots Analysis has done a detailed study on Proteome Profiling Services Market, 2020-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 8, 2021

Novel vaccine delivery devices market is worth USD 1.5 billion in 2030 (Roots Analysis)
Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies

April 8, 2021

“Novel Vaccine Delivery Devices Market, 2019-2030” (Roots Analysis)
A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers

April 8, 2021

under development products, are being investigated for the delivery of both liquid and solid formulations of vaccines
Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration.

April 8, 2021

Novel vaccine delivery devices market is worth USD 1.5 billion in 2030 (Roots Analysis)
Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative

April 8, 2021

‘Patient Recruitment and Retention Services, 2019-2030’ (Roots Analysis)
A detailed assessment of the current market landscape of companies offering patient recruitment and retention service

April 7, 2021

Close to 140 companies claim to be actively engaged in offering patient recruitment / retention services.
A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden

April 7, 2021

Patient recruitment and retention services market grow at an annualized rate of ~5%, (till 2030)
resently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions

April 7, 2021

Patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, (Roots Analysis)
Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”

April 7, 2021

‘Prefilled Syringes Market (5th edition), 2019-2030’ (Roots Analysis)
An overview of the current market landscape of companies engaged in manufacturing prefilled syringes

April 6, 2021

Presently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged (Roots Analysis)
Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device,

April 6, 2021

Prefilled syringes market is projected to grow at an annualized rate of ~5%, (till 2030)
Roots Analysis has done a detailed study on Prefilled Syringes, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 6, 2021

Prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, (Roots Analysis)
Despite having been available for more than two decades, the demand for prefilled syringes continues to grow

April 6, 2021

“Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” (Roots Analysis)
A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services

April 6, 2021